Protalix BioTherapeutics Inc (PLX)
1.18
+0.04
(+3.51%)
USD |
NYAM |
May 09, 12:53
Protalix BioTherapeutics Shares Outstanding: 73.05M for March 1, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
March 01, 2024 | 73.05M |
December 31, 2023 | 72.95M |
November 01, 2023 | 72.95M |
September 30, 2023 | 72.95M |
August 01, 2023 | 71.58M |
July 01, 2023 | 71.58M |
June 30, 2023 | 71.58M |
May 15, 2023 | 67.53M |
April 30, 2023 | 65.41M |
March 31, 2023 | 62.00M |
February 27, 2023 | 57.38M |
February 15, 2023 | 57.35M |
December 31, 2022 | 53.79M |
November 10, 2022 | 50.67M |
September 30, 2022 | 50.16M |
August 12, 2022 | 49.75M |
June 30, 2022 | 48.71M |
May 10, 2022 | 47.06M |
May 02, 2022 | 46.37M |
April 28, 2022 | 46.37M |
April 15, 2022 | 46.37M |
March 31, 2022 | 46.32M |
March 15, 2022 | 46.32M |
December 31, 2021 | 45.56M |
November 01, 2021 | 45.56M |
Date | Value |
---|---|
September 30, 2021 | 45.56M |
September 28, 2021 | 45.56M |
August 01, 2021 | 45.56M |
July 02, 2021 | 45.56M |
June 30, 2021 | 45.56M |
May 28, 2021 | 45.38M |
May 10, 2021 | 45.38M |
April 28, 2021 | 45.38M |
April 15, 2021 | 45.38M |
March 31, 2021 | 45.38M |
March 01, 2021 | 45.38M |
February 17, 2021 | 45.38M |
February 09, 2021 | 36.63M |
December 31, 2020 | 34.77M |
October 15, 2020 | 33.34M |
October 01, 2020 | 33.34M |
September 30, 2020 | 33.34M |
August 01, 2020 | 32.44M |
June 30, 2020 | 32.44M |
May 24, 2020 | 32.44M |
April 15, 2020 | 32.44M |
April 10, 2020 | 32.44M |
April 01, 2020 | 32.44M |
March 31, 2020 | 32.44M |
March 18, 2020 | 32.44M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
14.84M
Minimum
Jun 30 2019
73.05M
Maximum
Mar 01 2024
43.21M
Average
45.56M
Median
Jun 30 2021
Shares Outstanding Benchmarks
Agenus Inc | 20.95M |
InfuSystems Holdings Inc | 21.26M |
AIM ImmunoTech Inc | 49.90M |
Perspective Therapeutics Inc | 586.92M |
Armata Pharmaceuticals Inc | 36.15M |